- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imation receives large order for Canadian PACS site
Imation receives large order for Canadian PACS siteFilm and PACS vendor Imation has landed a large-scale PACS contract with the Manitoba healthcare system in Canada. The three-year pilot project, valued at $5 million (Canadian), for PACS, as
Imation receives large order for Canadian PACS site
Film and PACS vendor Imation has landed a large-scale PACS contract with the Manitoba healthcare system in Canada. The three-year pilot project, valued at $5 million (Canadian), for PACS, as well as associated wide-area networking equipment, will link up two Winnipeg teaching hospitals-St. Boniface General Hospital and Health Sciences Centre-with Grace Hospital in Ottawa, two rural hospitals, a clinic, and selected on-call physicians, according to Imation. The Canadian federal government and the Manitoba provincial government will each contribute $1.25 million toward the $5 million contract.
As part of the contract, Imation engineers will be working on-site at St. Boniface General Hospital to interface Imation's PACS to a wide-area network powered by high-speed asymmetric digital subscriber lines (ADSL). ADSL is a switching technology that utilizes existing copper telephone lines to rapidly transfer large-bandwidth files. St. Boniface plans to employ ADSL lines running at 1 MB per second, according to Imation of Oakdale, MN. Manitoba Telecom Services and St. Boniface General Hospital Research Centre will also be contributing to the project development effort.
- Search again
- Homepage
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
